Zhengye Biotechnology Holding Limited (ZYBT) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Zhengye Biotechnology Holding Limited (ZYBT) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $82.0M, listed on NASDAQ, employing roughly 269 people, carrying a beta of -2.69 to the broader market. Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. Led by Songlin Song, public since 2025-01-07.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for ZYBT as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →